Showing results (141-150 of 220) with videos related to
Sort By:
Pageof 22
BMC Health Services Research|November 10, 2016
The household economic burden for acute coronary syndrome survivors in AustraliaKarice K Hyun, Beverley M Essue, Mark Woodward, et al.European Journal of Cardiovascular Nursing|July 11, 2026
The spectrum of heart failure: prevalence and years lived with disability of heart failure across 2 severity levels and implications for health systems: a population-based comparative studyJialing Lin, Chuyi Zhou, Jinfeng Ding, et al.American Heart Journal|June 23, 2007
Relationship of ST elevation in lead aVR with angiographic findings and outcome in non-ST elevation acute coronary syndromesAndrew T Yan, Raymond T Yan, Brian M Kennelly, et al.Journal of the American Heart Association|November 2, 2019
ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?Stephen T Vernon, Sean Coffey, Mario D'Souza, et al.American Heart Journal|November 25, 2010
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary EventsMatthew Sibbald, Andrew T Yan, Wei Huang, et al.Heart (British Cardiac Society)|November 16, 2010
Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary EventsSanjit S Jolly, Heather Shenkman, David Brieger, et al.European Heart Journal. Quality of Care & Clinical Outcomes|February 14, 2018
Use of clinical risk stratification in non-ST elevation acute coronary syndromes: an analysis from the CONCORDANCE registryRong Bing, Shaun G Goodman, Andrew T Yan, et al.European Heart Journal. Acute Cardiovascular Care|December 16, 2014
High sensitivity-troponin elevation secondary to non-coronary diagnoses and death and recurrent myocardial infarction: An examination against criteria of causalityDerek P Chew, Tom G Briffa, Nasser J Alhammad, et al.Heart, Lung & Circulation|July 1, 2020
CSANZ Position Statement on the Evaluation of Patients Presenting With Suspected Acute Coronary Syndromes During the COVID-19 PandemicWilliam A Parsonage, Louise Cullen, David Brieger, et al.International Journal of Cardiology|April 4, 2016
Falling cholesterol trend at acute coronary syndrome presentation is strongly related to statin use for secondary preventionThomas Chan, Bilyana Dabin, Karice Hyun, et al.Pageof 22